Compounds > 4-hydroxy-n-phenyl-3,5-bis(1-pyrrolidinylmethyl)benzamide
Page last updated: 2024-09-04

4-hydroxy-n-phenyl-3,5-bis(1-pyrrolidinylmethyl)benzamide and Arrhythmia

4-hydroxy-n-phenyl-3,5-bis(1-pyrrolidinylmethyl)benzamide has been researched along with Arrhythmia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Funck-Brentano, C; Lineberry, MD; Pavlou, HN; Roden, DM; Woosley, RL1
Brown, BS; Calzadilla, SV; Diemer, MJ; Hartman, JC; Reynolds, RD1

Trials

1 trial(s) available for 4-hydroxy-n-phenyl-3,5-bis(1-pyrrolidinylmethyl)benzamide and Arrhythmia

ArticleYear
Prospective pharmacokinetically based development of effective infusion regimens for ACC-9358, a new antiarrhythmic drug.
    Clinical pharmacology and therapeutics, 1991, Volume: 49, Issue:3

    Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Pyrrolidines; Time Factors; Ventricular Function

1991

Other Studies

1 other study(ies) available for 4-hydroxy-n-phenyl-3,5-bis(1-pyrrolidinylmethyl)benzamide and Arrhythmia

ArticleYear
Antiarrhythmic, electrophysiologic and hemodynamic effects of ACC-9358.
    The Journal of pharmacology and experimental therapeutics, 1987, Volume: 243, Issue:3

    Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cats; Dogs; Electrocardiography; Female; Heart Conduction System; Heart Rate; Hemodynamics; In Vitro Techniques; Male; Myocardial Contraction; Pyrrolidines

1987